Loading...

VOR VOR BIOPHARMA INC Capital Structure Changes 8-K Filing

VR B

VR

VOR BIOPHARMA INC

(VOR)

2025 8-K

Summary

Summary

Stock Split Update

Corporate Presentation Update

Management Changes

Stockholder Approval

Licensing Agreement

Equity Offerings

Workforce Reduction

Noncompliance with Listing ...

Management Change

Stock Option Repricing

Board Appointment

Private Placement

Clinical Data Update

CFO Appointment

Resignation and Appointment

Equity Incentive Plan Amend...

Appointment of Director

Clinical Update

Annual Meeting of Stockholders

Resignation of Director

Clinical Update

External Links:

Vor Biopharma Inc. announced a 1-for-20 reverse stock split effective September 18, 2025, following approval from stockholders on August 25, 2025; this will reduce outstanding shares from approximately 136.8 million to about 6.8 million.

AI Assistant

VOR BIOPHARMA INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.